Cargando…

Exposure to psychotropic medications and mortality in schizophrenia: a 5-year national cohort study

BACKGROUND: Relatively few studies have explored the differential contributions of the accumulative dosage of psychotropic medications on mortality in patients with schizophrenia. METHODS: We aimed to explore the effects of the exposure dosage of psychotropic medications on mortality during a follow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ji-Yu, Yeh, Ling-Ling, Pan, Yi-Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482725/ https://www.ncbi.nlm.nih.gov/pubmed/36134676 http://dx.doi.org/10.1017/S0033291722002732

Ejemplares similares

National Prescribing Patterns of Psychotropic Medications in Older Adults in Oman
por: Al-Shehhi, Afaf, et al.
Publicado: (2023)

Pharmacokinetic interactions of psychotropic medications in patients with schizophrenia suffering from atypical mycobacterial infections
por: Sabaté, M. Betriu, et al.
Publicado: (2021)

Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study
por: Huybrechts, Krista F, et al.
Publicado: (2017)

Psychotropic drug utilization pattern among patients with schizophrenia
por: Dutta, Shakti Bala, et al.
Publicado: (2005)

The psychotropic effect of vitamin D supplementation on schizophrenia symptoms
por: Neriman, Aras, et al.
Publicado: (2021)

National trends in psychotropic medication prescribing before and during the COVID-19 pandemic()
por: Sanborn, Molly, et al.
Publicado: (2023)

Clinical predictors of psychotropic medication prescription in children with ASD of the ELENA cohort
por: Geoffray, Marie-maude, et al.
Publicado: (2023)

Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study
por: D'Andrea, G., et al.
Publicado: (2023)

Psychotropic medication treatment patterns in community-dwelling schizophrenia in China: comparisons between rural and urban areas
por: Hou, Cai-Lan, et al.
Publicado: (2019)

Psychotropic Medication Adherence and Its Associated Factors Among Schizophrenia Patients: Exploring the Consistency of Adherence Scales
por: Ali, Maghzoub M, et al.
Publicado: (2023)

Use of Clozapine for the Treatment of Schizophrenia: Findings of the 2006 Research on the China Psychotropic Prescription Studies
por: Si, Tian-Mei, et al.
Publicado: (2012)

FACTORS THAT INFLUENCE PSYCHOTROPIC MEDICATION USE
por: Resnick, Barbara, et al.
Publicado: (2019)

Cross-sectional associations of different types of nature exposure with psychotropic, antihypertensive and asthma medication
por: Turunen, Anu W, et al.
Publicado: (2023)

Workplace bullying and subsequent psychotropic medication: a cohort study with register linkages
por: Lallukka, Tea, et al.
Publicado: (2012)

Initiation of Psychotropic Medication after Partner Bereavement: A Matched Cohort Study
por: Shah, Sunil M., et al.
Publicado: (2013)

Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014
por: Lopez-Leon, Sandra, et al.
Publicado: (2018)

Management of Systemic Medical Emergencies Associated with Psychotropic Medications
por: Grover, Sandeep, et al.
Publicado: (2022)

Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership
por: Coe, Antoinette B., et al.
Publicado: (2022)

Multi-Exposure and Clustering of Adverse Childhood Experiences, Socioeconomic Differences and Psychotropic Medication in Young Adults
por: Björkenstam, Emma, et al.
Publicado: (2013)

Effects of Psychotropic Drugs on Quantitative EEG among Patients with Schizophrenia-spectrum Disorders
por: Hyun, June, et al.
Publicado: (2011)

Questionable Advertising of Psychotropic Medications and Disease Mongering
por: Lacasse, Jeffrey R, et al.
Publicado: (2006)

Clinicians’ predictions of patient response to psychotropic medications
por: Schulz, Pierre, et al.
Publicado: (2004)

Psychotropic Medications and the Risk of Sudden Cardiac Death
por: Huikuri, Heikki V.
Publicado: (2015)

Positive perception of pharmacogenetic testing for psychotropic medications
por: Lanktree, Matthew B, et al.
Publicado: (2014)

‘Prescribing’ psychotropic medication to our rivers and estuaries
por: Ford, Alex T., et al.
Publicado: (2019)

Effect of Psychotropic Medications on Hammertoe Reconstruction Outcomes
por: Maidman, Samuel D., et al.
Publicado: (2020)

Effects of psychotropic medications on pregnancy and breast feeding
por: LAD, ASHWINI, et al.
Publicado: (2022)

Gender Trends in Psychotropic Medication Use in Autism
por: Huber, Christopher R, et al.
Publicado: (2022)

Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021)

Editorial: Safety and side effects of psychotropic medications
por: de Filippis, Renato, et al.
Publicado: (2023)

Misuse of psychotropic medications among hospitalized patients
por: Azraf, F., et al.
Publicado: (2023)

Mortality and use of psychotropic medication in patients with stroke: a population-wide, register-based study
por: Jennum, Poul, et al.
Publicado: (2016)

Five-year mortality in a cohort of people with schizophrenia in Ethiopia
por: Teferra, Solomon, et al.
Publicado: (2011)

Effects of Preexisting Psychotropic Medication Use on a Cohort of Patients with Ischemic Stroke Outcome
por: Jun-O'Connell, Adalia H., et al.
Publicado: (2020)

Appropriateness of psychotropic medication use in a cohort of adolescents with intellectual disability in Queensland, Australia
por: Song, Menghuan, et al.
Publicado: (2020)

Trends in Psychotropic Medication Prescriptions in Urban China From 2013 to 2017: National Population-Based Study
por: Xu, Lu, et al.
Publicado: (2021)

Psychotropic drug-prescribing correlates of disorganized speech in Asians with schizophrenia: The REAP-AP study
por: Park, Yong Chon, et al.
Publicado: (2019)

Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856
por: Begni, Veronica, et al.
Publicado: (2021)

Influence of Psychotropic Pro Re Nata Drug Use on Outcomes in Hospitalized Patients with Schizophrenia
por: Kyou, Yoshitaka, et al.
Publicado: (2023)

Psychotropic drugs
por: Keltner, Norman L.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_5h1midg8i57dgnhtq5tnp4duss